Roxas and Company, Inc. (PSE:RCI)

Kronos Bio Revenue

Roxas and Company had revenue of 195.48M PHP in the quarter ending March 31, 2025, with 35.44% growth. This brings the company's revenue in the last twelve months to 577.71M, down -19.48% year-over-year. In the year 2024, Roxas and Company had annual revenue of 526.56M, down -31.87%.

• Revenue (ttm): 577.71M
• Revenue Growth: -19.48%
• P/S Ratio: 17.04
• Revenue / Employee: 1.60M
• Employees: 360
• Market Cap: 9.85B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	526.56M	-246.27M	-31.87%
Dec 31, 2023	772.82M	-48.67M	-5.92%
Dec 31, 2022	821.49M	-124.02M	-13.12%
Dec 31, 2021	945.51M	445.36M	89.04%
Dec 31, 2020	500.15M	-333.65M	-40.02%